Germline BRCA1-2 mutations in non-Ashkenazi families with double primary breast and ovarian cancer

Gynecologic Oncology
J O SchorgeGail E Tomlinson

Abstract

Ashkenazi women with double primary breast and ovarian cancer have a high prevalence (57%) of germline Jewish founder mutations in the BRCA1 (185delAG, 5382insC) and BRCA2 (6174delT) genes. The purpose of this study was to determine the frequency and type of BRCA1-2 mutations in non-Ashkenazi families with at least one member having double primary breast and ovarian cancer. Women at increased risk for cancer based upon their family history were enrolled at the University of Texas Southwestern Familial Cancer Registry between 1992 and 2000. Blood samples from patients desiring genetic testing were sent for complete DNA sequencing of the BRCA1 and BRCA2 genes. Families with a member having both breast and ovarian cancer were identified and clinical data were obtained. Sixty-two (7%) of 900 enrolled families were non-Ashkenazi and had at least one member with double primary breast and ovarian cancer. Twenty-one families had members who underwent genetic testing; 41 did not. Thirteen (62%) families had a germline BRCA1 (n = 11) or BRCA2 (n = 2) mutation; only one Jewish founder mutation (185delAG) was detected. Eight (38%) families tested negative. Six (86%) of seven women undergoing genetic testing who themselves had double primar...Continue Reading

References

Jan 1, 1993·Human Mutation·A L Beaudet, L C Tsui
Nov 1, 1996·Nature Genetics·S MazoyerG M Lenoir
Feb 5, 1997·Journal of the National Cancer Institute·D A BerryE Winer
Jun 19, 1998·American Journal of Human Genetics·P HuuskoR Winqvist
Oct 30, 1998·American Journal of Human Genetics·P N ToninS A Narod
Apr 10, 1999·Human Molecular Genetics·S A JanezicH Anton-Culver

❮ Previous
Next ❯

Related Concepts

Related Feeds

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.